Novavax’s COVID-19 booster is now authorized in Europe


Shares of Novavax Inc. NVAX, +0.35% were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax’s stock has declined 77.3% so far this year, while the S&P 500 SPX, +0.96% is down 14.6%.

This article was originally published by Read the original article here.

Previous articleMarket Snapshot: U.S. stock futures point to fourth day of gains for Wall Street
Next articleAll but one Dow stock in positive territory as index runs up gain of 350 points


Please enter your comment!
Please enter your name here